InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Explore the detailed record of transactions filed by ALTSHULER DAVID, Directeur Exécutif, Recherche Globale et Directeur Scientifique. Director active across 2 companies, notably VERTEX PHARMACEUTICALS INC / MA. Cumulatively, 10 reports have been logged. Total volume traded: €506k. The latest transaction was disclosed on 24 February 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
€1m6,038 shares@ €201.54450.0011% mcap38.5% of flow
Common Stock
SEC:0000899243-22-008109:0·
€702,9303,439 shares@ €204.39950.0006% mcap22.3% of flow
Common Stock
SEC:0000899243-22-007203:0·
€498,9482,444 shares@ €204.15210.0004% mcap15.8% of flow
Common Stock
SEC:0001209191-22-010175:0·
€732,2753,518 shares@ €208.15090.0007% mcap23.2% of flow
Common Stock
SEC:0001209191-22-009232:0·
08,166 shares0
Common Stock
SEC:0001209191-22-006757·
08,166 shares0
Common Stock
SEC:0001209191-22-006757:0·
€2,28614 shares@ €163.263261.7% of flow
Common Stock
SEC:0001209191-21-064731·
€2,28614 shares@ €163.26320.0000% mcap0.1% of flow
Common Stock
SEC:0001209191-21-064731:0·
€1,4178 shares@ €177.109738.3% of flow
Common Stock
SEC:0001209191-21-033983·
€1,4178 shares@ €177.10970.0000% mcap0.0% of flow
Common Stock
SEC:0001209191-21-033983:0·
10 of 10 declarations
About ALTSHULER DAVID
David Altschuler is Executive Vice President of Global Research and Chief Scientific Officer at Vertex Pharmaceuticals Inc., a biopharmaceutical company. In this role, he oversees research and development efforts, contributing to innovation in the treatment of serious diseases.
